← signals
2026-07-09·AAPL·new product launch
highup

A Manifold market shows 77.34% consensus that Apple will release an AI chip for iPhones in 2026.

A Manifold market shows 77.34% consensus that Apple will release an AI chip for iPhones in 2026. This would mark Apple's entry into dedicated AI silicon for mobile devices, potentially reducing reliance on third-party AI accelerators. The high probability suggests strong belief in Apple's internal AI chip development timeline. Such a move would impact Apple's supply chain (TSMC likely to manufacture) and competitive positioning against NVIDIA in edge AI. The source market question: 'Will Apple release an AI chip for iPhones in 2026?'. What the sources said: - Source Manifold - Apple AI chip: 'Will Apple release an AI chip for iPhones in 2026?' (77.34% yes, indicating a strong market expectation).

window 90devidence 2confidence score 57price AAPL $313.39

confidence score

Watch item: useful signal, but still thin or early.

57
high confidence1 independent source classesmarketmedium high without independent sourcespasses publish gate
priced-in check

AAPL has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-07-087d n/a45d n/a90d +20%yahoo

signal brief

A Manifold market shows 77.34% consensus that Apple will release an AI chip for iPhones in 2026. This would mark Apple's entry into dedicated AI silicon for mobile devices, potentially reducing reliance on third-party AI accelerators. The high probability suggests strong belief in Apple's internal AI chip development timeline. Such a move would impact Apple's supply chain (TSMC likely to manufacture) and competitive positioning against NVIDIA in edge AI. The source market question: 'Will Apple release an AI chip for iPhones in 2026?'.

What the sources said:

  • Source Manifold - Apple AI chip: 'Will Apple release an AI chip for iPhones in 2026?' (77.34% yes, indicating a strong market expectation).

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.